Literature DB >> 33313690

COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations.

Michael P Lunn1,2, David R Cornblath3, Bart C Jacobs4,5, Luis Querol6, Peter A van Doorn4, Richard A Hughes1, Hugh J Willison7.   

Abstract

Entities:  

Year:  2020        PMID： 33313690     DOI： 10.1093/brain/awaa444

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  24 in total

Review 1.  A review of adverse effects of COVID-19 vaccines.

Authors:  Hisham Ahmed Mushtaq; Anwar Khedr; Thoyaja Koritala; Brian N Bartlett; Nitesh K Jain; Syed Anjum Khan
Journal:  Infez Med       Date:  2022-03-01

Review 2.  Case Series of Guillain-Barré Syndrome After the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine.

Authors:  Miranda Mengyuan Wan; Angela Lee; Ronak Kapadia; Christopher Hahn
Journal:  Neurol Clin Pract       Date:  2022-04

3.  Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.

Authors:  Arina A Tamborska; Bhagteshwar Singh; Sonja E Leonhard; Eva Maria Hodel; Julia Stowe; Taylor Watson-Fargie; Peter M Fernandes; Andreas C Themistocleous; Jacob Roelofs; Kathryn Brennan; Caroline Morrice; Benedict D Michael; Bart C Jacobs; Helen McDonald; Tom Solomon
Journal:  BMJ Neurol Open       Date:  2022-07-12

4.  Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.

Authors:  J I Castiglione; J M Crespo; L Lecchini; F O Silveira; M B Luis; N Cotti; C J Simison; F Aguirre; M A Piedrabuena; R N Alonso; C L Azcona; P S Sosa; E Maldonado; F Barroso
Journal:  Neuromuscul Disord       Date:  2022-05-11       Impact factor: 3.538

Review 5.  Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis.

Authors:  Lina Palaiodimou; Maria-Ioanna Stefanou; Aristeidis H Katsanos; Paraskevi C Fragkou; Marianna Papadopoulou; Christos Moschovos; Ioannis Michopoulos; Panagiotis Kokotis; Christos Bakirtzis; Androniki Naska; Theodoros I Vassilakopoulos; Elisabeth Chroni; Sotirios Tsiodras; Georgios Tsivgoulis
Journal:  Eur J Neurol       Date:  2021-04-28       Impact factor: 6.288

Review 6.  COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

Authors:  Arens Taga; Giuseppe Lauria
Journal:  J Peripher Nerv Syst       Date:  2022-03-14       Impact factor: 5.188

7.  Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association.

Authors:  Osakpolor Ogbebor; Harshit Seth; Zaw Min; Nitin Bhanot
Journal:  IDCases       Date:  2021-04-30

8.  Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barre syndrome.

Authors:  Michael P Lunn; Aisling C Carr; Stephen Keddie; Julia Pakpoor; Menelaos Pipis; Hugh J Willison
Journal:  Brain       Date:  2021-04-03       Impact factor: 13.501

Review 9.  A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.

Authors:  Medha Karnik; Narasimha M Beeraka; Chinnappa A Uthaiah; Suma M Nataraj; Anjali Devi S Bettadapura; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Mol Neurobiol       Date:  2021-06-05       Impact factor: 5.590

10.  Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine.

Authors:  Michele Trimboli; Pio Zoleo; Gennarina Arabia; Antonio Gambardella
Journal:  Neurol Sci       Date:  2021-08-04       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.